Atherosclerosis in Rheumatoid Arthritis Tekijä Miguel A. González-Gay, Zoltan Szekanecz, Calin D. Popa, Patrick Dessein

Hae kokoteksti

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals Tekijä Calin D. Popa, Elke Arts, Jaap Fransen, Piet L. C. M. van Riel

Hae kokoteksti

Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial Tekijä Merel Hartog, Kyra A. L. van Keeken, Cornelia H. M. van den Ende, Calin D. Popa

Hae kokoteksti

Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort study Tekijä Daphne C. Rohrich, Eline H. M. van de Wetering, Alexander J. Rennings, Elke E. Arts, Inger L. Meek, Alfons A. den Broeder, Jaap Fransen, Calin D. Popa

Hae kokoteksti

Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial Tekijä Maarten Boers, Michael T Nurmohamed, Calin D Popa, Dirkjan van Schaardenburg, Marian van Beers-Tas, Laurette van Boheemen, Samina Turk, Wouter Bos, Diane Marsman, Ed N Griep, Mirian Starmans-Kool, Alper van Sijl

Hae kokoteksti